From challenge to innovation: a narrative review on innovation in nephrology and hemodialysis randomized trials
Vasileios C. Pezoulas(University of Ioannina), Giovanni F M Strippoli(The University of Sydney), Carmine Zoccali(Biogem), Krister Cromm(Humboldt-Universität zu Berlin), Nikolaos Tachos(University of Ioannina), D I Fotiadis(University of Ioannina), Giovanni Tripepi(Istituto di Fisiologia Clinica)
Cited by 0
Related Papers
Obesity and Kidney Disease: Hidden Consequences of the Epidemic
|American Journal of Nephrology|2017|2.2k
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study
|The Lancet|2001|1.1k
Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria
|The Lancet|1999|909
A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases
|Kidney International|2019|886
An introduction to inverse probability of treatment weighting in observational research
|Clinical Kidney Journal|2021|877